Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL1718183 | 0.89 | CHRM2 (0.33) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| Acetic Acid SCHEMBL1716931 | 0.87 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| Bicarbonate SCHEMBL1718187 | 0.87 | CHRM2 (0.35) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| Trifluoroacetic Acid SCHEMBL907242 | 0.87 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| Trifluoroacetic Acid SCHEMBL907493 | 0.87 | CCR5 (0.31) | — | |
| Trifluoroacetic Acid SCHEMBL907539 | 0.84 | CHRM2 (0.33) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| Trifluoroacetic Acid SCHEMBL907760 | 0.84 | CHRM2 (0.30) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| Trifluoroacetic Acid SCHEMBL907385 | 0.84 | CCR5 (0.34) | — | |
| Trifluoroacetic Acid SCHEMBL907227 | 0.82 | — | — | |
| SCHEMBL1717537 | 0.81 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CYP2D6CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7875732-B2 | Quaternary ammonium salt, electrolyte, electrolyte, solution and electrochemical device | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-01-25 | — | — | US | disclosed |
| US-20080050657-A1 | N-methoxymethyl-N-methylpyrrolidinium trifluoromethanesulfonate; high solubility in organic solvents, high electroconductivity, voltage resistance; environmentally friendly; use in lithium battery; double layer capacitors | STELLA CHEMIFA CORPORATION (JP) | 2008-02-28 | — | — | US | disclosed |
| EP-1837333-A1 | QUATERNARY AMMONIUM SALT, ELECTROLYTE, ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE | Otsuka Chemical Co., Ltd. (JP) | 2007-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080050657-A1 | N-methoxymethyl-N-methylpyrrolidinium trifluoromethanesulfonate; high solubility in organic solvents, high electroconductivity, voltage resistance; environmentally friendly; use in lithium battery; double layer capacitors | CACNA1F, KCNN2, KCNN3 | CHRM2 127/4885CHRM4 106/4885CHRM5 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.